VITAL PORTFOLIO
Vaccine
Implementation
Translation,
Access &
Learning
Only 32.8% of high-risk adults aged 50–74, received an RSV vaccine*
Many eligible people are never identified, informed, or supported to receive recommended vaccinations.
The Case for Change
67
%
Never
got a
Vaccine*.
The
Opportunity
Every vaccination opportunity represents a chance to prevent the trajectory of respiratory disease
What makes VITAL different?
PRELIMINARY RESULTS IN 4 WEEKS*
IDENTIFY
Find people who may benefit
UNDERSTAND
Learn what is getting in the way
PERSONALIZE
Provide the right support
LEARN
Improve what works
PHASE 1 ACTIVITIES
Convene
Patients, Emergency Medicine, Pulmonology, health systems, and sponsoring organizations
Design
Develop patient identification criteria, referral pathways, and diagnostic workflows
Pilot
Test the model in real-world UC/ED setting
Measure
Evaluate implementation, diagnostic acceleration, and patient engagement
Scale
Expand successful approaches across health systems and respiratory diseases